Heparin-Akrihin 1000 gel for external use, 1000 IU / g, 30 g

Heparin-Akrihin 1000 gel d / nar.

approx.

1000IU / g tube 30g

Name ENG

HEPARIN-AKRIKHIN 1000

Clinical and pharmacological group

Drug with antithrombotic action for external use

ATX code

Heparin

Dosage

1000IU / g x 30g

Structure

1 g of gel contains: active substance: heparin 1000 ME ,.

excipients: methyl parahydroxybenzoate, carbomer 940 or 980, trometamol, rectified ethyl alcohol, lavender oil, neroli oil, purified water.

Indications

bruises of soft tissues and joints

localized infiltrates and swelling of soft tissues

thrombophlebitis of superficial veins

tendon and joint injuries.

Storage conditions and periods

At a temperature of 15-25 degrees.

Expiration date: 2 years

INN / Active ingredient

Heparin sodium

Contraindications

ulcerative necrotic changes in the skin at the sites of the intended application of the drug

traumatic violation of the integrity of the skin

thrombocytopenia

decreased blood clotting

known hypersensitivity to any component of the drug.

Specifications

Category

Diseases of the veins

Scope of the drug

Heart, vessels, blood

Release form

Gel

Manufacturer country

Russia

Package quantity, pcs

one

Scope of application

Cardiology

,

Angiology

,

Phlebology

Way of introduction

Locally

,

Outwardly

Vacation conditions

Without recipe

Brand name

Akrikhin

The amount of the dosage form in the primary package

30 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

C05BA03 Heparin sodium

Dosage form

Gel for external use

Packaging

Box

Expiration date in days

730

Dosage (volume) of the substance in the preparation

sodium heparin 100,000 IU (0.83 g)

The target audience

Adult

Package weight, g

40

Mode of application

:

Outwardly.

Gel Heparin-Akrigel 1000 is applied in a thin layer to the affected area at the rate of 3-5 cm of gel on a skin with a diameter of 3-5 cm and gently rubbed into the skin.

Apply 1-3 times a day every day until the inflammation disappears, on average from 3 to 7 days.

Pharmaco-therapeutic group

:

Direct-acting anticoagulant for topical use